Presented by Tel-Aviv University, this is a unique, intensive four-day program focusing on the critical elements in the formation, launch and strategic and operational management of health-related technologies, with a particular focus on companies developing enabling technologies in biotechnology, medical devices and healthcare IT.
Cooley special counsel Brian Hopkins will be speaking on the panel titled: Intellectual Capital Management on November 28 at 9 am. This session will provide insight into the specific issues confronting investigators, entrepreneurs, investors and their patent attorneys. The panel will address the formation of specific IP strategy and execution and using intellectual capital for competitive advantage. Content includes major issues confronting companies with US and filings in other jurisdictions related to biotechnology, patent ownership, non-obviousness rulings, and the scope of what can be patented. A VC will also provide an investor viewpoint.
Event details and registration